Certified into the record
The exact text we saved
This is the version exactly as it was saved, character for character. The SHA-256 hash below is a 64-character code worked out from that text. Run the same text through SHA-256 and you get the same code; change a single letter and the code comes out completely different. Each version also stores the previous version’s hash, which chains them together so no version can be swapped out quietly.
TRUVACE RECORD VERSION record: TRV-2026-2970 version: 1 kind: certified reason: Certified into the record timestamp: 2026-11-16T18:01:37.446206Z status: published lens: g_space sector: health headline: Can AI-assisted analysis of antidepressant drug online reviewers (ADORE) inform real-world use of antidepressants? dek: Antidepressant selection is constrained by limited comparative-effectiveness data, with randomized trials measuring symptom reduction rather than patient-reported tolerability. We tested whether AI-assisted analysis of patient-written online reviews recovers drug-level tolerability signals that converge with the strongest randomized evidence. We did a cross-sectional analysis of 8348 reviews of 16 antidepressants for major depressive disorder posted to Drugs.com (February 2008-March 2025; ≥1 month reported use).… gain_title: In a cross-sectional analysis of 8,348 Drugs.com reviews of 16 antidepressants, two AI models agreed closely (mean κ 0.81), and review ratings correlated strongly with randomized-trial retention odds ratios (ρ = +0.79). problem_title: (none) trace_subject: (none) gain_reading: In a cross-sectional analysis of 8,348 Drugs.com reviews of 16 antidepressants, two AI models agreed closely (mean κ 0.81), and review ratings correlated strongly with randomized-trial retention odds ratios (ρ = +0.79). gain_evidence: Mean inter-LLM Cohen's κ was 0.81 | Top rating correlated strongly with Cipriani et al. retention odds ratios (ρ = +0.79, p < 0.001) problem_reading: (none) problem_evidence: (none) quick_read: Researchers analysed 8,348 patient-written reviews of 16 antidepressants taken for major depressive disorder, posted to Drugs.com between February 2008 and March 2025. Two AI models, Claude Sonnet 4.5 and Gemini 2.5 Pro, sorted each review across 17 clinical dimensions. Each drug's share of top ratings correlated strongly (ρ = +0.79) with retention odds ratios from the 2018 Cipriani network meta-analysis. The result matters because randomized trials usually measure symptom reduction, not how well patients tolerate a drug. Top ratings did not track efficacy odds ratios (ρ = -0.14, p = 0.64), and emotional blunting was the strongest negative predictor of satisfaction (odds ratio 0.20). The authors also found substantial differences within the SNRI class. The findings are presented as a hypothesis-generating signal. Reviews come from one platform and from self-selected users, the drug-level comparison rests on few agents, and the design is cross-sectional and ecological. limitation: Reviews come from a single platform and self-selected users, drug-level comparisons rest on few agents, and the design is cross-sectional and ecological. tag: Evidence-backed gain key_points: The study covered 8,348 Drugs.com reviews of 16 antidepressants for major depressive disorder, posted February 2008 to March 2025, from users reporting at least one month of use. | Claude Sonnet 4.5 and Gemini 2.5 Pro classified each review across 17 clinical dimensions using identical structured prompts. | Mean agreement between the two AI models was κ = 0.81; two experts rated a 100-review subsample and agreed with the AI consensus at mean κ = 0.75 and 0.80. | Top-rating prevalence correlated with retention odds ratios from the 2018 Cipriani network meta-analysis (ρ = +0.79, p < 0.001). | Top rating did not correlate with efficacy odds ratios (ρ = -0.14, p = 0.64). | Emotional blunting was the strongest negative predictor of satisfaction, with an odds ratio of 0.20. | Heterogeneity within the SNRI class was substantial. rundown: The team used a cross-sectional design. Only reviews describing at least one month of use were included. Two large language models classified every review with the same structured prompts, and a stratified 100-review subsample (1,700 classifications per reviewer) was rated independently by two experts. All agreement statistics were highly significant. To test validity, the researchers compared each drug's share of top ratings with the retention and efficacy odds ratios from Cipriani and colleagues' 2018 network meta-analysis, using Spearman correlation. Ratings followed retention closely but not efficacy. The authors conclude that, among contemporary antidepressants with comparable efficacy, tolerability, especially emotional blunting, correlates most with patient satisfaction. They describe the SNRI differences as a hypothesis-generating signal. sources: - peer_reviewed | Journal of Affective Disorders | https://doi.org/10.1016/j.jad.2026.122743 | 2026-11-15 prev: 0000000000000000000000000000000000000000000000000000000000000000
- SHA-256 hash
- 2b959512f4c41b73d1624480dd1fc5e66ca897b00073bc2ed2c5d63a0469ee90
- Previous version’s hash
- 0000000000000000000000000000000000000000000000000000000000000000
How to check it yourself, without trusting this page
Download any version from /api/record/TRV-2026-2970 and hash its canonical field yourself, for example with shasum -a 256. You should get its content_hash. Each version’s text also ends with prev:and the hash of the version before it (version 1 points to 64 zeros). If anyone had changed a single character of any version after it was saved, those hashes wouldn’t line up.
ace